🚀 VC round data is live in beta, check it out!
Oxiquim Valuation Multiples
Discover revenue and EBITDA valuation multiples for Oxiquim and similar public comparables like Selena FM, Natac Natural Ingredients, Ercros, Messer Tehnogas and more.
Oxiquim Overview
About Oxiquim
Oxiquim SA focuses on the marketing of chemical products and the provision of services related to the chemical sector. It is engaged in the production, transformation, sale, export, and distribution of all types of chemical, petrochemical, pharmaceutical, cosmetic, and general chemical products. The company's other business activities include the provision of engineering and maintenance services, the operation and exploitation of maritime terminals, and the production and sale of resins and adhesive mixtures. The company's operating segments are; Commercial which derives maximum revenue, and Services.
Founded
1980
HQ
Employees
428
Website
Sectors
Financials (FY)
EV
$390M
Oxiquim Financials
Oxiquim reported last fiscal year revenue of $259M and EBITDA of $41M.
In the same fiscal year, Oxiquim generated $90M in gross profit, $41M in EBITDA, and $29M in net income.
Oxiquim P&L
In the most recent fiscal year, Oxiquim reported revenue of $259M and EBITDA of $41M.
Oxiquim expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $259M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $90M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 35% | XXX | XXX | XXX |
| EBITDA | — | XXX | $41M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 13% | XXX | XXX | XXX |
| Net Profit | — | XXX | $29M | XXX | XXX | XXX |
| Net Margin | — | XXX | 11% | XXX | XXX | XXX |
| Net Debt | — | — | $52M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Oxiquim Stock Performance
Oxiquim has current market cap of $339M, and enterprise value of $390M.
Market Cap Evolution
Oxiquim's stock price is $13.64.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $390M | $339M | 1.5% | XXX | XXX | XXX | $1.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOxiquim Valuation Multiples
Oxiquim trades at 1.5x EV/Revenue multiple, and 9.4x EV/EBITDA.
Oxiquim Financial Valuation Multiples
As of April 3, 2026, Oxiquim has market cap of $339M and EV of $390M.
Equity research analysts estimate Oxiquim's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Oxiquim has a P/E ratio of 11.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $339M | XXX | $339M | XXX | XXX | XXX |
| EV (current) | $390M | XXX | $390M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 9.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 11.8x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.3x | XXX | XXX | XXX |
| P/E | — | XXX | 11.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 15.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Oxiquim Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Oxiquim Margins & Growth Rates
Oxiquim's revenue in the last fiscal year grew by 1%.
Oxiquim's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.1M for the same period.
Oxiquim Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (5%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Oxiquim Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Selena FM | XXX | XXX | XXX | XXX | XXX | XXX |
| Natac Natural Ingredients | XXX | XXX | XXX | XXX | XXX | XXX |
| Ercros | XXX | XXX | XXX | XXX | XXX | XXX |
| Messer Tehnogas | XXX | XXX | XXX | XXX | XXX | XXX |
| Aduro Clean Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Oxiquim M&A Activity
Oxiquim acquired XXX companies to date.
Last acquisition by Oxiquim was on XXXXXXXX, XXXXX. Oxiquim acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Oxiquim
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOxiquim Investment Activity
Oxiquim invested in XXX companies to date.
Oxiquim made its latest investment on XXXXXXXX, XXXXX. Oxiquim invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Oxiquim
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Oxiquim
| When was Oxiquim founded? | Oxiquim was founded in 1980. |
| Where is Oxiquim headquartered? | Oxiquim is headquartered in Chile. |
| How many employees does Oxiquim have? | As of today, Oxiquim has over 428 employees. |
| Is Oxiquim publicly listed? | Yes, Oxiquim is a public company listed on Bolsa de Santiago. |
| What is the stock symbol of Oxiquim? | Oxiquim trades under OXIQUIM ticker. |
| When did Oxiquim go public? | Oxiquim went public in 2015. |
| Who are competitors of Oxiquim? | Oxiquim main competitors are Selena FM, Natac Natural Ingredients, Ercros, Messer Tehnogas. |
| What is the current market cap of Oxiquim? | Oxiquim's current market cap is $339M. |
| What is the current revenue of Oxiquim? | Oxiquim's last fiscal year revenue is $259M. |
| What is the current EV/Revenue multiple of Oxiquim? | Current revenue multiple of Oxiquim is 1.5x. |
| Is Oxiquim profitable? | No, Oxiquim is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.